Before the BARDA funding grant the share price was roughly $1. Even though this stockmarket is totally irrational, it is rational to say that the BARDA funding was NOT built into that low, suppressed shareprice of $1
Now we have $250 million BARDA funding and the shareprice has increased 30 cents to now be at around $1.30. Biota's market capitalisation has increased from $185 million to $240 million.
So a $250 million BARDA grant (with the end major 'prize' being the preferred supplier of the very significant US government stockpiling market) is valued today by the stockmarket to be worth $55 million.
$250 million + $x = $55 million
Does not compute
$250 million BARDA grant + future Inavir stockpiling dollars + strong advanced pipeline of 3 drugs + Inavir Japan royalties + Relenza royalties + $90 million cash in bank equals $??????, however current Market cap = $240 million
Does not compute
Sticklers may 'discount' that 250 million because it is over five years, but it still does not compute.
- Forums
- ASX - By Stock
- BTA
- does not compute
does not compute
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla